BE1003250A5 - Derives du monophosphoryllipide a et leur preparation. - Google Patents

Derives du monophosphoryllipide a et leur preparation. Download PDF

Info

Publication number
BE1003250A5
BE1003250A5 BE8801207A BE8801207A BE1003250A5 BE 1003250 A5 BE1003250 A5 BE 1003250A5 BE 8801207 A BE8801207 A BE 8801207A BE 8801207 A BE8801207 A BE 8801207A BE 1003250 A5 BE1003250 A5 BE 1003250A5
Authority
BE
Belgium
Prior art keywords
derivatives
monophosphoryllipid
preparation
lipid
radicals
Prior art date
Application number
BE8801207A
Other languages
English (en)
French (fr)
Inventor
R Myers Kent
S Ribi Karin
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Application granted granted Critical
Publication of BE1003250A5 publication Critical patent/BE1003250A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
BE8801207A 1987-10-22 1988-10-20 Derives du monophosphoryllipide a et leur preparation. BE1003250A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/112,742 US4987237A (en) 1983-08-26 1987-10-22 Derivatives of monophosphoryl lipid A

Publications (1)

Publication Number Publication Date
BE1003250A5 true BE1003250A5 (fr) 1992-02-11

Family

ID=22345625

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8801207A BE1003250A5 (fr) 1987-10-22 1988-10-20 Derives du monophosphoryllipide a et leur preparation.

Country Status (10)

Country Link
US (1) US4987237A (https=)
JP (1) JPH075623B2 (https=)
BE (1) BE1003250A5 (https=)
CA (1) CA1308711C (https=)
CH (1) CH676715A5 (https=)
DE (1) DE3836006C2 (https=)
FR (1) FR2622192A1 (https=)
GB (1) GB2211502B (https=)
IT (1) IT1230592B (https=)
NL (1) NL8802595A (https=)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158939A (en) * 1989-07-21 1992-10-27 Wisconsin Alumni Research Foundation Method of stimulating the immune systems of animals and compositions useful therefor
WO1991001146A1 (en) * 1989-07-14 1991-02-07 Praxis Biologics, Inc. Cytokine and hormone carriers for conjugate vaccines
US5498708A (en) * 1989-07-18 1996-03-12 Montefiore Medical Center Method of synthesizing polyesters
EP0482206A4 (en) * 1990-04-12 1992-08-19 Japan Tobacco Inc. 4,6-o-hydroxyphosphorylglucosamine derivative
US5653974A (en) * 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
US5164375A (en) * 1991-09-27 1992-11-17 Merck & Company, Inc. Antifungal agent
US5648343A (en) * 1994-02-28 1997-07-15 The University Of Georgia Research Foundation Method for treating LPS-mediated disorders
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
US5681824A (en) * 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US6290971B1 (en) * 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) * 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
US20040002068A1 (en) 2000-03-01 2004-01-01 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
EP2000144A1 (en) 2000-05-19 2008-12-10 Corixa Corporation Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
EP1482795B1 (en) * 2002-02-04 2009-11-11 Corixa Corporation New immunoeffector compounds
US6911434B2 (en) * 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
WO2003073827A2 (en) * 2002-02-28 2003-09-12 Corixa Corporation Methods of modulating dendritic cells using adjuvants
US20030224013A1 (en) * 2002-04-19 2003-12-04 Cole Garry T. Methods for protection against Coccidioides spp. infection using Coccidioides spp. urea amidohydrolase (Ure) protein
RU2340621C2 (ru) 2002-07-08 2008-12-10 Корикса Корпорейшн Способы получения аминоалкилглюкозаминидфосфатов и дисахаридных иммуноэффекторов и их промежуточных соединений
CA2512108C (en) 2003-01-06 2013-04-02 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
US7960522B2 (en) 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
DK1449535T3 (da) * 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
WO2006073921A2 (en) * 2004-12-30 2006-07-13 The Rockefeller University Compositions and methods for enhanced dendritic cell maturation and function
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
US7622128B2 (en) * 2005-12-13 2009-11-24 University Of Washington Porphyromonas gingivalis 1435/1449 LPS as an immune modulator
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PT2468300T (pt) 2006-09-26 2018-01-30 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
EP2173376B1 (en) * 2007-08-02 2015-03-25 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
US20090215908A1 (en) * 2007-09-24 2009-08-27 Reliance Life Sciences Pvt. Ltd. Toll like receptor (tlr) signaling antagonist
US20090215710A1 (en) * 2007-09-24 2009-08-27 Reliance Life Sciences Pvt. Ltd. Carbohydrate based toll-like receptor (tlr) antagonists
WO2009073179A2 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
CN102481312B (zh) 2009-06-05 2015-07-15 传染性疾病研究院 合成的吡喃葡萄糖脂佐剂
CA2828068C (en) 2011-02-22 2019-03-19 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2012141984A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
GB201106802D0 (en) 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
KR102136433B1 (ko) 2012-05-16 2020-07-22 이뮨 디자인 코포레이션 Hsv-2 백신
JP6494527B2 (ja) 2013-02-07 2019-04-03 ザ チルドレンズ メディカル センター コーポレーション 肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
ES2743431T3 (es) 2013-02-20 2020-02-19 Bergen Teknologioverfoering As Vacuna
EP2986303B1 (en) 2013-04-18 2020-02-26 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3024476A1 (en) 2013-07-26 2016-06-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of bacterial infections
WO2016180852A1 (en) 2015-05-12 2016-11-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for preparing antigen-specific t cells from an umbilical cord blood sample
KR20250006307A (ko) 2017-09-13 2025-01-10 사노피 파스퇴르 인간 시토메갈로바이러스 면역원성 조성물
US20190275134A1 (en) 2018-03-12 2019-09-12 Janssen Pharmaceuticals, Inc Vaccines against urinary tract infections
CN113195520A (zh) 2018-08-24 2021-07-30 挪威西部创新股份有限公司 作为抗腹泻疫苗抗原的热稳定肠毒素突变体
MX2022004061A (es) 2019-10-02 2022-07-19 Janssen Vaccines & Prevention Bv Peptidos de estafilococo y metodos de uso.
LT4090363T (lt) 2020-01-16 2024-09-25 Janssen Pharmaceuticals, Inc. Fimh mutantas, kompozicijos su juo ir jų panaudojimas
US11725028B2 (en) 2021-01-12 2023-08-15 Janssen Pharmaceuticals, Inc. FimH mutants, compositions therewith and use thereof
KR20230164108A (ko) 2021-04-01 2023-12-01 얀센 파마슈티칼즈, 인코포레이티드 E. coli O18 생물접합체의 생산

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62129293A (ja) * 1985-11-28 1987-06-11 Toho Yakuhin Kogyo Kk 親水性のリピドａ単糖類縁体
JPS62195396A (ja) * 1986-02-20 1987-08-28 Toho Yakuhin Kogyo Kk 親水性及び疎水性の基を置換したりピドａ単糖類縁体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0414725Y2 (https=) * 1980-09-30 1992-04-02
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62129293A (ja) * 1985-11-28 1987-06-11 Toho Yakuhin Kogyo Kk 親水性のリピドａ単糖類縁体
JPS62195396A (ja) * 1986-02-20 1987-08-28 Toho Yakuhin Kogyo Kk 親水性及び疎水性の基を置換したりピドａ単糖類縁体

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BIOMEDICAL MASS SPECTROMETRY, vol. 11, no. 3, mars 1984, pages 132-141; U. SEYDEL et al.: "Laser desorption mass spectrometry of synthetic lipid A-like compounds" *
CHEMISTRY LETTERS, 1980, pages 1373-1376, Tokyo, JP; M. INAGE et al.: "Chemical synthesis of bisdephospho lipid A of Salmonella endotoxin" *
INFECTION AND IMMUNITY, vol. 44, no. 2, mai 1984, pages 421-426, Washington, D.C., US; K.-I. TANAMOTO et al.: "Biological activities of synthetic lipid A analogs; Pyrogenicity lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate" *
PATENT ABSTRACTS OF JAPAN, vol. 11, no. 357 (C-458)[2804], 20 novembre 1987; & JP-A-62 129 293 (TOHO YAKUHIN KOGYO K.K.) 11-06-1987 *
PATENT ABSTRACTS OF JAPAN, vol. 12, no. 50 (C-476)[2897], 16 février 1988; & JP-A-62 195 396 (TOHO YAHUKIN KOGYO K.K.) 28-08-1987 *
TETRAHEDRON LETTERS, vol. 21, 1980, pages 3889-3892, Oxford, GB; M. INAGE et al.: "Synthesis of lyposaccharide corresponding to fundamental structure of Salmonella-type lipid A" *
TETRAHEDRON LETTERS, vol. 22, no. 24, 1981 pages 2281-2284, Oxford, GB; M. INAGE et al.: "Chemical synthesis of phosphorylated fundamental structure of lipid A" *
TETRAHEDRON LETTERS, vol. 24, no. 19, 1983, pages 2011-2014, Oxford, GB; M. INAGE et al.: "Synthetic approach to lipid A: Preparation of phosphorylated disaccharides containing (R)-3-hydroxyacyl and (R)-3-acyloxyacyl groups" *

Also Published As

Publication number Publication date
NL8802595A (nl) 1989-05-16
FR2622192A1 (fr) 1989-04-28
US4987237A (en) 1991-01-22
FR2622192B1 (https=) 1994-11-10
GB8824330D0 (en) 1988-11-23
CH676715A5 (https=) 1991-02-28
IT8822399A0 (it) 1988-10-21
DE3836006C2 (de) 1996-07-11
JPH01146891A (ja) 1989-06-08
DE3836006A1 (de) 1989-05-03
JPH075623B1 (https=) 1995-01-25
CA1308711C (en) 1992-10-13
GB2211502A (en) 1989-07-05
JPH075623B2 (ja) 1995-01-25
GB2211502B (en) 1992-02-19
IT1230592B (it) 1991-10-28

Similar Documents

Publication Publication Date Title
BE1003250A5 (fr) Derives du monophosphoryllipide a et leur preparation.
IL73521A0 (en) Preparation of intermediate compounds for the synthesis of nucleosides and certain such novel compounds
PL288592A1 (en) Method of obtaining novel derivatives of 3-aminopiperidine
HUT34212A (en) Process for the production of new vindblastin conjugates
FI851355A0 (fi) Komposition och apparat foer bestaemning av leukocyter, esteras och proteas i ett prov.
HUT64604A (en) Method for producing endo-bicyclo(2,2,1)-heptane-2-ol derivatives and enzymatical separating the substance obtaine therefrom
KR100222606B1 (en) Process for preparation of beta-lactams
RU95112464A (ru) Способ получения производных таксана
DE3853538D1 (de) Glykosidester und verfahren zur enzymatischen herstellung.
HUT49379A (en) Process for producing demannosyl teichoplanin derivatives and pharmaceutical compositions comprising same
DK467288A (da) 4`-deshydroxyepipodophyllotoxinglucosider
FR2625996B1 (fr) Procede de preparation d'agents d'hydroxyalkylation, les nouveaux agents ainsi obtenus et leur emploi
ES553608A0 (es) Procedimiento de preparacion de 21-hidroxi-20-ceto-delta16-esteroides
ATE111092T1 (de) Antibiotikum a80915 und verfahren zu seiner herstellung.
DD210709A1 (de) Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b
HUT60927A (en) Process for producing pharmaceutical composition inhibiting the formation of activated lymphocytes
EP0455170A3 (en) Process for culturing microorganisms of the genus pseudomonas and process for producing l-alanine using said microorganisms
ATE113608T1 (de) Antibiotikum.
AU8274987A (en) New process for manufacturing optically active carbocycline intermediates
AU8003387A (en) Acylation products of bis(2-imidazolin-2-ylhydrazones) of 9,10-anthracenedicarboxaldehyde
MX9100686A (es) Procedimiento para la produccion de 4-pregneno-3,20-dion y productos derivados
NO159537C (no) Fremgangsmaate for fremstilling av antibiotikum sb 22484 ved fermentering av streptomyces sp nrrl 15496.
DE3853390D1 (de) Verfahren zur Herstellung von phosphodiester-Konjugaten, die bei der Herstellung der immunaktiven Liposomen verwendbar sind.
HUT58064A (en) Process for producing new n-benzyl tetrahydrofurane carboxamide derivatives
KR970043061A (ko) 발효에 의한 l-쓰레오닌의 제조방법

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *RIBI IMMUNOCHEM RESEARCH INC.

Effective date: 20081020